Title of Collaborative Activity: |
Newborn Drug Development Planning Committee |
Description of Collaborative Activity: |
Primary responsibility for administering, contracting, and monitoring studies to develop Investigational new drug application data for potential label modification. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2011 |
NIH Participating Institutes/Centers/Office of the Director: |
NHLBI, NICHD, NLM |
HHS Agency Collaborators on this Activity: |
FDA |
